Analysis of cyclooxygenase-2 expression in human breast cancer: high throughput tissue microarray analysis
- 1 July 2003
- journal article
- Published by Springer Science and Business Media LLC in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 129 (7), 375-382
- https://doi.org/10.1007/s00432-003-0459-1
Abstract
The objective of this study was to evaluate breast carcinomas for the expression of cyclooxygenase-2 (Cox-2) using a tissue microarray (TMA) and to determine its clinical and prognostic relevance.This publication has 41 references indexed in Scilit:
- Expression of Cyclooxygenase 2 Is an Independent Prognostic Factor in Human Ovarian CarcinomaThe American Journal of Pathology, 2002
- Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.2002
- The mRNA Expression of Cyclo-oxygenase-2 (COX-2) and Vascular Endothelial Growth Factor (VEGF) in Human Breast CancerCurrent Medical Research and Opinion, 2002
- Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2Nature Reviews Cancer, 2001
- Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growthGastroenterology, 2001
- Cyclooxygenase-2: a target for the prevention and treatment of breast cancer.Endocrine-Related Cancer, 2001
- Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.2000
- Human cyclooxygenase-2 cDNA.Proceedings of the National Academy of Sciences of the United States of America, 1992
- Aspirin use and chronic diseases: a cohort study of the elderly.BMJ, 1989
- Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence.Proceedings of the National Academy of Sciences of the United States of America, 1988